Mirae Asset Global Investments Co., Ltd. Bicycle Therapeutics PLC Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,342 shares of BCYC stock, worth $27,376. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,342
Previous 1,072
25.19%
Holding current value
$27,376
Previous $21,000
42.86%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BCYC
# of Institutions
112Shares Held
41.2MCall Options Held
39.6KPut Options Held
24.6K-
Baker Bros. Advisors LP New York, NY9.4MShares$192 Million2.28% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.55MShares$72.4 Million2.97% of portfolio
-
Fcpm Iii Services B.V. Naarden, P72.34MShares$47.7 Million9.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA2.25MShares$46 Million0.71% of portfolio
-
Armistice Capital, LLC New York, NY1.96MShares$39.9 Million0.74% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $605M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...